This page is not available in the language that has been selected and will appear in English.
This page is not available in the language that has been selected.
Halaman ini tidak tersedia dalam bahasa yang dipilih.
Trang này không có sẵn bằng ngôn ngữ đã chọn.
此页面不提供所选语言的版本。
1234 5678
John hits the road to celebrate the end of cancer treatment.
John hits the road to celebrate the end of cancer treatment
Sed aliquam tellus sit amet lectus suscipit molestie. Curabitur nec ultrices nunc, id feugiat nisi. Nam iaculis malesuada ex eget dictum.
Find a clinical trial that suits you and your cancer diagnosis
BGB-A317-26808-101
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
Locations Adelaide
Diagnosis Advanced solid tumours
LOXO-ENC-23001 / J5A-OX-JZWA
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
BGB-A317-A3055-101
A Study of BGB-A3055, Alone and in Combination With Tislelizumab in Participants With Selected Advanced or Metastatic Solid Tumors
Locations South Brisbane
LEGEND / EG-70-101
EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Diagnosis Bladder cancer
BG-C137-101
A First-in-Human Study of BG-C137, an Anti-FGFR2b Antibody Drug Conjugate, in Participants With Advanced Solid Tumors
KLK2-comPAS / 78278343PCR3001
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Diagnosis Prostate cancer